| Pharmaceutical active ingredients: |
| Ethionamide |
| Available forms, composition and doses of Tubenamide: |
| N / A |
| Tubenamide medical category: |
| Human:AntileproticsAnti-TB agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J04AD03 - Ethionamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tubazid | Isoniazid | Unidentified Pharmaceutical Company |
| Tubazide | Isoniazid | Unidentified Pharmaceutical Company |
| Tubazole | Thiabendazole | Unidentified Pharmaceutical Company |
| Tubeco | Isoniazid | Unidentified Pharmaceutical Company |
| Tubecotubercid | Isoniazid | Unidentified Pharmaceutical Company |
| Tuberactinomycin B | Viomycin | Unidentified Pharmaceutical Company |
| Tuberbut | Tobramycin | Kampar Laboratorio; LKM Laboratorio |
| Tubercazon | Thioacetazone | Unidentified Pharmaceutical Company |
| Tuberculin PPD Mantoux | Tuberculin Protein Derivative Purified | Sanofi-Aventis |
| Tuberculin PPD RT 23 | Tuberculin Protein Derivative Purified | Statens Serum Institute; DKSH |